PERSPECTA

News from every angle

← Back to headlines

Aytu BioPharma, Seer Report Mixed Quarterly Earnings

Aytu BioPharma reported a GAAP EPS miss but beat revenue estimates, while Seer missed both GAAP EPS and revenue expectations in their latest financial disclosures.

13 May, 20:27 — 13 May, 20:27
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed98d ago

Aytu BioPharma GAAP EPS of -$0.53 misses by $0.02, revenue of $12.4M beats by $0.35M

Read full article →

Related Stories

Moderna and Merck Announce Breakthrough in Cancer Vaccine Development

21m ago

DEA Joins Investigation into Death of Hayden Panettiere

1h ago

Bayern Munich's Jamal Musiala Reveals Neurological Dysfunction Diagnosis

3h ago

Black Bear Dies After Being Trapped in Unlocked Car in Colorado

6h ago